Overview:
The study involved four major activities to estimate the current size of the human organoids market. Exhaustive secondary research was carried out to collect information on the market and its different subsegments. The next step was to validate these findings, assumptions, and sizing with industry experts across the value chain through primary research. Top-down and bottom-up approaches were employed to estimate the complete market size. Thereafter, market breakdown and data triangulation procedures were used to estimate the size of segments and subsegments.
Market Size Estimation:
Both top-down and bottom-up approaches were used to estimate and validate the total size of the clinical microbiology market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:
# The key players in the industry and markets have been identified through extensive secondary research
# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research
# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources
Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=171046468
By product, liver segment is expected to have the largest market share during the forecast period
The large share of this segment is attributed to factors such as the significant adoption of new technologies among researchers and academia (coupled with growing industry-academia collaborations for genomic research), technological advancements in the field of 3D bioprinting and the increased number of liver tranplants and diseases.
Developmental biology is the largest application segment of the human orgnaoids market
Developmental biology includes the production of gametes, fertilization, development of the embryo, emergence of the adult organism, and senescence. Organoids developed from stem cells or tissues in culture can be converted into structures that resemble the in vivo anatomy and physiology of intact organs. Human organoid cultures provide the potential to study the human development and model disease processes with the same depth of analysis customary for research with nonhuman model organisms. Technological advancements in the field of 3D bioprinting have shown huge potential for organ development as the culture time is very less compared to traditional methods of tissue culture. Patient-derived human organoid studies may accelerate medical research, creating new opportunities for tissue engineering and regenerative medicine and generating knowledge and tools for preclinical studies, including drug development and testing.
Pharmaceuticals & Biotechnology companies accounted for the largest share of the human organoids market, by end users, in 2020
Pharmaceutical and biotechnology companies mainly focus on developing new drugs for the treatment of various rare diseases. These companies need to submit specific data related to drug development during the drug development process and subsequent filing of applications to regulatory bodies. This necessitates a wide spectrum of services in the early development phases and clinical phases to comply with regulatory requirements. Technical and regulatory challenges related to the development of new drug molecules create complexities for pharmaceutical and biotechnology companies in terms of time and cost. However, due to strict regulations, companies often produce technologically superior products with better safety norms.
North America is the largest regional market for Human Organoids
North America (comprising the US and Canada) dominates the human orgnaoids market. North America is a mature market, with high penetration of human organoids technologies among key end users (pharmaceuticals & biotechnology companies, CROs, academia and others) and well-established distribution channels for human organoids product manufacturers and suppliers. Easy accessibility to and the high adoption of advanced technologies due to the significant per capita annual healthcare expenditure by the US and Canadian governments, as well as supportive government regulations, are driving the growth of the human organoids market in this region.
Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=171046468
Key Market Players
BioIVT (US), Thermo Fisher Scientific (US), ZenBio (US), Corning (US), Organovo (US), Cyprio (France), Biopredic International (France), CELLINK (Sweden), Emulate (US), Hµrel Corporation (US), InSphero (Switzerland), Kerafast (US), Kirkstall (UK), and MIMETAS (Netherlands).
About MarketsandMarkets™
MarketsandMarkets™ provides quantified B2B research on 30,000 high growth niche opportunities/threats which will impact 70% to 80% of worldwide companies’ revenues. Currently servicing 7500 customers worldwide including 80% of global Fortune 1000 companies as clients. Almost 75,000 top officers across eight industries worldwide approach MarketsandMarkets™ for their painpoints around revenues decisions.
Our 850 fulltime analyst and SMEs at MarketsandMarkets™ are tracking global high growth markets following the "Growth Engagement Model – GEM". The GEM aims at proactive collaboration with the clients to identify new opportunities, identify most important customers, write "Attack, avoid and defend" strategies, identify sources of incremental revenues for both the company and its competitors. MarketsandMarkets™ now coming up with 1,500 MicroQuadrants (Positioning top players across leaders, emerging companies, innovators, strategic players) annually in high growth emerging segments. MarketsandMarkets™ is determined to benefit more than 10,000 companies this year for their revenue planning and help them take their innovations/disruptions early to the market by providing them research ahead of the curve.
MarketsandMarkets’s flagship competitive intelligence and market research platform, "Knowledgestore" connects over 200,000 markets and entire value chains for deeper understanding of the unmet insights along with market sizing and forecasts of niche markets.
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
The global Organoids Market research report, published by Value Market Research, is designed to offer various market framework such as market size, portion, trends, growth path, value and factors that impact the current market dynamics over the forecast period 2020-2027.
Most importantly, this report also provides the latest significant strategies adopted by major players along with their market share.The research report also covers the comprehensive profiles of the key players in the market and an in-depth view of the competitive landscape worldwide.
The major players in the Organoids Market include STEMCELL Technologies, Inc., Hubrecht Organoid Technology, 3Dnamics, Inc, Definigen, PeproTech, Inc., Corning Incorporated (Life Sciences), Cellesce Ltd., Organoid Therapeutics, Thermo Fisher Scientific, and Merck KGgA..
This section includes a holistic view of the competitive landscape that includes various strategic developments such as key mergers & acquisitions, future capacities, partnerships, financial overviews, collaborations, new product developments, new product launches, and other developments.Get more information on "Global Organoids Market Research Report" by requesting FREE Sample Copy at https://www.valuemarketresearch.com/contact/organoids-market/download-sampleMarket SegmentationThe broad Organoids Market has been sub-grouped into the Type, Application, Source and Region.
The report studies these subsets with respect to the geographical segmentation.
The strategists can gain a detailed insight and devise appropriate strategies to target specific market.
Thus, the rising focus on substituting animal model for research, along with development of commercially available organoids, is likely to boost the growth of the global organoids market.According to the latest report published by FMI, the global organoids market is expected to reach ~ US$ 134 Mn by the forecast year 2029.
The report further projects that the organoids market will grow at a CAGR of ~ 15% during the forecast period 2019-2029.Request a Sample Report with Table of Contents and Figures: https://www.futuremarketinsights.com/reports/sample/rep-gb-8106Organoids and 3D cell cultures are growing rapidly in popularity, replacing 2D cell culture in traditional methods of research in human developmental biology.
In the past few years, a mounting number of pharma companies have been focusing on introducing personalised oncology drugs, and leading stakeholders are joining the bandwagon by adopting strategies of creating cancer organoids for individual patients, in order to leverage the new avenues of growth in oncology research.Organoids Market: DynamicsOver the last few years, organoids have gained significant popularity among the research groups working on advanced 3D cell culture.
The primary driver for the organoids market is considered to be the attainment of greater degree of resemblance to the cell specific structure of the specific organ, in vivo environmental conditions.
The ability of organoids to meticulously mimic the specific cells of the organs from which they are derived, leads to accurate models of tissues.
This factor is expected to play an instrumental role in driving the growth of the organoids market.Preview Analysis Global Organoids Market By Product Type: Intestinal organoids have high commercial potential, Neural organoids grow fastest in demand; By Application Type: High Applicability in Bio-banking, Biomedical research and drug discovery create new opportunities: https://www.futuremarketinsights.com/reports/organoids-marketEurope Takes the Centre Stage in the Organoids Market Lack of skilled professionals engaged in research and developmental activities is expected to hamper the growth of the organoids market.
Thus, the rising focus on substituting animal model for research, along with development of commercially available organoids, is likely to boost the growth of the global organoids market.According to the latest report published by FMI, the global organoids market is expected to reach ~ US$ 134 Mn by the forecast year 2029.
The report further projects that the organoids market will grow at a CAGR of ~ 15% during the forecast period 2019-2029.Organoids and 3D cell cultures are growing rapidly in popularity, replacing 2D cell culture in traditional methods of research in human developmental biology.
In the past few years, a mounting number of pharma companies have been focusing on introducing personalised oncology drugs, and leading stakeholders are joining the bandwagon by adopting strategies of creating cancer organoids for individual patients, in order to leverage the new avenues of growth in oncology research.Organoids Market: DynamicsOver the last few years, organoids have gained significant popularity among the research groups working on advanced 3D cell culture.
The primary driver for the organoids market is considered to be the attainment of greater degree of resemblance to the cell specific structure of the specific organ, in vivo environmental conditions.
The ability of organoids to meticulously mimic the specific cells of the organs from which they are derived, leads to accurate models of tissues.
This factor is expected to play an instrumental role in driving the growth of the organoids market.Europe Takes the Centre Stage in the Organoids Market Lack of skilled professionals engaged in research and developmental activities is expected to hamper the growth of the organoids market.
